Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
31.75
-0.05 (-0.16%)
Aug 19, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Revenue
Nang Kuang Pharmaceutical had revenue of 538.59M TWD in the quarter ending June 30, 2026, a decrease of -0.58%. This brings the company's revenue in the last twelve months to 2.11B, down -7.50% year-over-year. In the year 2025, Nang Kuang Pharmaceutical had annual revenue of 2.16B, down -1.71%.
Revenue (ttm)
2.11B
Revenue Growth
-7.50%
P/S Ratio
1.52
Revenue / Employee
3.82M
Employees
552
Market Cap
3.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.16B | -37.64M | -1.71% |
| Dec 31, 2024 | 2.20B | 49.63M | 2.31% |
| Dec 31, 2023 | 2.15B | 209.74M | 10.81% |
| Dec 31, 2022 | 1.94B | 160.39M | 9.01% |
| Dec 31, 2021 | 1.78B | 25.27M | 1.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.44B |
| Formosa Optical Technology | 4.39B |
| St.Shine Optical | 3.73B |
| Pacific Hospital Supply | 2.42B |
| Bionime | 1.72B |
| Chi Sheng Pharma & Biotech | 1.42B |
| ICARES Medicus | 1.21B |
| SciVision Biotech | 889.15M |